BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33036926)

  • 1. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
    Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.
    Benedict J; Magill G
    Emerg Top Life Sci; 2019 Nov; 3(6):681-686. PubMed ID: 32915212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Immunosuppression Regimens in Hand, Face, and Kidney Transplantation.
    Rifkin WJ; Manjunath AK; Kantar RS; Jacoby A; Kimberly LL; Gelb BE; Diaz-Siso JR; Rodriguez ED
    J Surg Res; 2021 Feb; 258():17-22. PubMed ID: 32977237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local immunosuppression in vascularized composite allotransplantation (VCA): A systematic review.
    Safi AF; Kauke M; Nelms L; Palmer WJ; Tchiloemba B; Kollar B; Haug V; Pomahač B
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):327-335. PubMed ID: 33229219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant management and sensitisation in vascularised composite allotransplantation: A systematic review.
    Geoghegan L; Al-Khalil M; Scarborough A; Murray A; Issa F
    J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1593-1603. PubMed ID: 32475735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports.
    Van Dieren L; Tawa P; Coppens M; Naenen L; Dogan O; Quisenaerts T; Lancia HH; Oubari H; Dabi Y; De Fré M; Thiessen Ef F; Cetrulo CL; Lellouch AG
    J Surg Res; 2024 Jun; 298():137-148. PubMed ID: 38603944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase.
    Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Strategies in Transplantation: Genetic Engineering and Vascularized Composite Allotransplantation.
    Kauke-Navarro M; Noel OF; Knoedler L; Knoedler S; Panayi AC; Stoegner VA; Huelsboemer L; Pomahac B
    J Surg Res; 2023 Nov; 291():176-186. PubMed ID: 37429217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and long-term outcomes in vascularized composite allotransplantation.
    Kaufman CL; Ouseph R; Marvin MR; Manon-Matos Y; Blair B; Kutz JE
    Curr Opin Organ Transplant; 2013 Dec; 18(6):652-8. PubMed ID: 24220047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation - a retrospective study.
    Weissenbacher A; Vrakas G; Chen M; Reddy S; Allan P; Giele H; Barnardo MCNM; Vaidya A; Friend PJ; Fuggle SV
    Transpl Int; 2018 Apr; 31(4):398-407. PubMed ID: 29150964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
    Moris D; Cendales LC
    Front Immunol; 2021; 12():682180. PubMed ID: 34456906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal Donor-Recipient Strain Combinations Present Different Vascularized Composite Allotransplantation Outcomes in Rodent Models.
    Cheng HY; Lin CF; Anggelia MR; Lai PC; Shih LY; Liu SC; Wei FC; Lin CH
    Plast Reconstr Surg; 2023 Jun; 151(6):1220-1231. PubMed ID: 36508453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation.
    Schweizer R; Taddeo A; Waldner M; Klein HJ; Fuchs N; Kamat P; Targosinski S; Barth AA; Drach MC; Gorantla VS; Cinelli P; Plock JA
    Am J Transplant; 2020 May; 20(5):1272-1284. PubMed ID: 31774619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.